| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 46,019 | 42,646 | 40,554 | 42,152 | | Cost of Revenue | 13,638 | 13,365 | 11,825 | 12,347 | | | Gross Profit |
-
| 29,281 | 28,729 | 29,805 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,668 | 16,822 | 15,248 | 13,747 | | Non Recurring | (314) | 314 |
-
|
-
| | Others | 8,233 | 19,137 | 15,800 | 29,003 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (6,992) | (2,319) | (12,945) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 9,794 | (6,992) | (2,319) | (12,945) | | Interest Expense | 3,835 | 3,785 | 3,795 | 4,042 | | Income Before Tax | 5,959 | (10,777) | (6,114) | (16,987) | | Income Tax Expense | 2,018 | (4,769) | (2,934) | (7,134) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,941 | (6,008) | (3,180) | (9,853) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,941 | (6,008) | (3,180) | (9,853) | | Preferred Stock And Other Adjustments | (1,069) | (1,069) | (1,068) | (474) | | | Net Income Applicable To Common Shares | $2,872 | ($7,077) | ($4,248) | ($10,327) |
|
0.49% Nasdaq 0.00%
Income Statement
